Patent Assignment
Reel/Frame 043882/0511
License
Recorded: 2017-09-18
Pages: 73
Assignor
APEIRON BIOLOGICS AG
Executed: 2016-09-27
Assignee
EUSA PHARMA (UK) LIMITED
BREAKSPEAR PARK, BREAKSPEAR WAY, HEMEL HEMPTSTEAD, HP24TZ, UNITED KINGDOM
Covered Properties
(4)
Method for Treating a GD2 Positive Cancer
Method for Treating a GD2 Positive Cancer
Application:
14/086,696 →
Method for Treating a GD2 Positive Cancer
Preparations and Methods for Treating a GD2 Positive Cancer
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 16, 2014
From: LOIBNER, HANS; MUTSCHLECHNER, OLIVER; LADENSTEIN, RUTH; KLIER, ISABEL
To: APEIRON BIOLOGICS AG
Reel/Frame 032682/0889 →
Assignment of Assignor's Interest
Mar 18, 2015
From: LOIBNER, HANS; SCHUSTER, MANFRED; JANZEK-HAWLAT, EVELYNE; WIEDERKUM, SUSANNE
To: APEIRON BIOLOGICS AG
Reel/Frame 035193/0855 →
Corrective Assignment to Correct the Conveying Party Data Previously Recorded on Reel 035193 Frame 0855. Assignor(S) Hereby Confirms the Assignment.
Jul 29, 2016
From: LOIBNER, HANS; SCHUSTER, MANFRED; JANZEK-HAWLAT, EVELYNE; WIEDERKUM, SUSANNE
To: APEIRON BIOLOGICS AG
Reel/Frame 039507/0472 →
Assignment of Assignor's Interest
Sep 26, 2016
From: LOIBNER, HANS; MUTSCHLECHNER, OLIVER; LADENSTEIN, RUTH; KLIER, ISABEL
To: APEIRON BIOLOGICS AG
Reel/Frame 039859/0098 →
Change of Name
Dec 10, 2024
From: APEIRON BIOLOGICS AG
To: APEIRON BIOLOGICS GMBH
Reel/Frame 069584/0365 →
Security Interest
Dec 23, 2024
From: APEIRON BIOLOGICS GMBH
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 069669/0908 →